MedTrace Logo

Evaluating Peanut Immunotherapy Dissolving Film in Healthy Subjects

NCT03070561 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2017-03-03

No results posted yet for this study

Summary

Open label, cross-over, local pharmacokinetics study of a sublingual film with peanut extract in healthy adults and children

Conditions

Interventions

BIOLOGICAL

sublingual film with peanut extract

Sponsors & Collaborators

Principal Investigators

  • Corinne Keet, MD, PhD · Johns Hopkins University

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
3 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-01-14
Primary Completion
2015-05-31
Completion
2015-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03070561 on ClinicalTrials.gov